ZINC ACETATE - Generic Drug Details

What are the generic drug sources for zinc acetate and what is the scope of patent protection?

Zinc acetate is the generic ingredient in one branded drug marketed by Eton and is included in one NDA. Additional information is available in the individual branded drug profile pages.

Two suppliers are listed for this compound.

Summary for ZINC ACETATE

US Patents:	0
Tradenames:	1
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	2
Raw Ingredient (Bulk) Api Vendors:	95
Clinical Trials:	1,437
What excipients (inactive ingredients) are in ZINC ACETATE?	ZINC ACETATE excipients list
DailyMed Link:	ZINC ACETATE at DailyMed

Recent Clinical Trials for ZINC ACETATE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Guiying Wang	PHASE2
Second Xiangya Hospital of Central South University	PHASE1
Trust Fertility Clinic	PHASE4

See all ZINC ACETATE clinical trials

Pharmacology for ZINC ACETATE

Drug Class	Copper Absorption Inhibitor
Physiological Effect	Decreased Copper Ion Absorption

Anatomical Therapeutic Chemical (ATC) Classes for ZINC ACETATE

A16AX	Various alimentary tract and metabolism products
A16A	OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
A16	OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
A	Alimentary tract and metabolism

US Patents and Regulatory Information for ZINC ACETATE

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Eton	GALZIN	zinc acetate	CAPSULE;ORAL	020458-001	Jan 28, 1997		RX	Yes	No
Eton	GALZIN	zinc acetate	CAPSULE;ORAL	020458-002	Jan 28, 1997		RX	Yes	Yes

ZINC ACETATE Market Analysis and Financial Projection

Last updated: February 17, 2026

What Is the Current Market Size and Demand for Zinc Acetate?

The global zinc acetate market was valued at approximately USD 131 million in 2022. It is projected to grow at a compound annual growth rate (CAGR) of around 4.2% from 2023 to 2030, reaching USD 180 million by 2030. Key driver is the increasing adoption in dietary supplements and pharmaceutical applications.

Demand stems primarily from two sectors:

• Dietary supplements: Zinc acetate is used as a zinc supplement to prevent or treat zinc deficiency.
• Pharmaceutical applications: It serves as an active ingredient in treatments for various conditions, notably for managing Wilson’s disease and in topical formulations.

Regional demand concentrates in North America and Europe, driven by health awareness and regulatory approval. Asian markets, especially China and India, exhibit rapid growth due to expanding pharmaceutical manufacturing capacity and dietary supplement consumption.

How Does Supply Chain Influence Market Dynamics?

Global supply chains for zinc acetate face pressure from increases in raw zinc prices and geopolitical disruptions. Zinc prices surged from around USD 2,800 per metric ton in 2021 to over USD 3,200 in mid-2022, influenced by global zinc demand and limited mine outputs.

Manufacturing concentrated in China accounts for roughly 70% of global production, exposing the supply to risks from policy changes, environmental restrictions, and export tariffs. Countries like India and South Korea are developing domestic manufacturing to reduce dependency.

Raw material availability influences pricing, with fluctuations affecting profit margins for producers.

What Are the Competitive Landscape and Key Players?

The market has a handful of leading producers, including:

• Shandong Jinshunda Import & Export Co., Ltd.
• AKC Ltd. (India)
• American Zinc Recycling
• EverZinc

These companies hold significant market shares, with Shandong Jinshunda and AKC jointly controlling about 55% of production capacity as of 2022.

Product differentiation primarily involves purity levels. Pharmaceutical-grade zinc acetate (≥99.99% purity) commands premium prices, while industrial-grade products are lower cost but used less in pharmaceuticals.

Major players invest in capacity expansion and R&D to develop formulations with improved bioavailability and stability. Strategic mergers, acquisitions, and joint ventures appear prevalent to broaden market reach.

What Are Regulatory and Policy Factors Shaping the Trajectory?

Regulatory standards impact product approvals, manufacturing practices, and import-export policies.

• In the US, the FDA classifies zinc acetate as generally recognized as safe (GRAS) for supplement use.
• The European Medicines Agency (EMA) has approved zinc acetate for certain indications, tightening regulations for pharmaceutical products.
• China’s Ministry of Industry and Information Technology (MIIT) promotes domestic capacity expansion, with emphasis on environmental compliance.

Trade policies influence supply and prices. For example, tariffs introduced in 2021 by the US on Chinese zinc products elevated costs for downstream manufacturers.

In terms of environmental regulation, stricter controls on zinc mining and processing are increasing operational costs, which could restrain supply growth.

What Are the Financial Trends and Investment Perspectives?

Most leading firms report stable revenues with gradual increases aligned with market growth projections.

• Companies like AKC Ltd. increased revenue by 5-7% annually over the past three years.
• Margin improvements occur through process optimization and premium product focus.

Market entry for new players is challenging due to high capital requirements and supply chain complexities.

Investors view zinc acetate's primary markets—supplements and pharmaceuticals—as stable, with prospects for diversification into emerging markets such as animal health.

However, volatility in raw material prices and regulatory landscape pose financial risks.

How Is R&D Influencing Future Offerings and Market Potential?

R&D efforts are concentrated on enhancing bioavailability and developing new formulations. Patent filings related to zinc acetate delivery systems increased by 15% annually from 2018-2022.

Innovations include microencapsulation and combination therapies with other minerals or drugs. These advances aim to expand therapeutic indications and improve patient compliance.

Despite technological advances, patent expirations for key formulations could intensify competition and commoditize certain grades.

Key Takeaways

• The zinc acetate market is projected to grow at a CAGR of 4.2%, reaching USD 180 million by 2030.
• Demand is driven by dietary supplements, pharmaceutical applications, and regional health trends.
• China dominates global supply, exposing the market to geopolitical and regulatory risks.
• Product differentiation focuses on purity levels; pharmaceutical-grade zinc acetate commands higher prices.
• Regulatory policies vary but generally facilitate supplement use; pharmaceutical approval processes are more stringent.
• Raw zinc prices and environmental regulations influence supply costs and capacity expansions.
• Major firms maintain stable revenues; new entrants face high barriers.
• R&D progress is expanding potential applications but faces patent and competition risks.

5 Frequently Asked Questions

1. What are the primary applications of zinc acetate?
It is used mainly in dietary supplements to prevent zinc deficiency and in pharmaceuticals for conditions such as Wilson’s disease and cold sore treatments.

2. How does zinc acetate's market growth compare globally?
Expected CAGR is approximately 4.2%, with faster growth in Asia due to rising healthcare awareness and manufacturing capacity.

3. Who are the leading producers of zinc acetate?
Shandong Jinshunda and AKC Ltd. dominate, holding over 50% of market share in capacity.

4. What factors pose risks to supply stability?
Zinc price volatility, geopolitical issues, environmental regulations, and China’s dominant manufacturing role present risks.

5. What opportunities exist for future development?
Advances in formulation technology and expanding markets in emerging economies offer growth pathways, provided patent and regulatory challenges are managed.

---

Citations:

[1] MarketsandMarkets, "Zinc Acetate Market," 2023.
[2] Global Zinc Price Index, 2021-2022.
[3] Industry reports on pharmaceutical regulatory policies, 2022.
[4] Company filings and annual reports, 2022.
[5] World Bank, "Global Zinc Production," 2022.